Annual EBITDA
$449.17M$39.88M-8.15%
Summary
- Current Value
- As of today, ALKS annual EBITDA is $449.17M, down -8.15% on
- Historical Performance
- ALKS annual EBITDA is up +809.89% over the past 3 years, and up +9001.70% over the past 5 years
- All-Time High Comparison
- ALKS annual EBITDA is currently -8.15% below its historical high of $489.05M set on
- 3-Year Low Comparison
- ALKS annual EBITDA is +525.82% above its 3-year low of $71.77M reached on an earlier date
- Sector Comparison
- ALKS annual EBITDA is higher than 91.02% of companies in Healthcare sector
EBITDA Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $449.17M | -8.2% | +809.9% | +9001.7% | +2594.3% | |
| Quarterly EBITDA | $97.16M | -13.0% | +336.7% | +880.2% | +2014.5% | |
| TTM EBITDA | $388.71M | +10.3% | +1072.4% | +329.9% | +1341.9% | |
| Price | $29.36 | +2.9% | +8.3% | +42.6% | +132.8% | |
| PE Ratio | 14.53 | +11.0% | – | – | – | |
| Annual Revenue | $1.56B | -6.4% | +32.7% | +33.0% | +773.7% | |
| Annual EPS | $2.17 | +3.5% | +824.9% | +273.3% | +616.5% | |
| Annual EBIT | $420.64M | +1.6% | +1536.3% | +657.3% | +1077.5% | |
| Annual Net Income | $372.14M | -28.3% | +872.6% | +289.3% | +1039.1% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $489.05M | -8.2% | |
| 5Y | $489.05M | -8.2% | |
| All | $489.05M | -8.2% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $71.77M | N/A | +525.8% |
| 5Y | -$30.57M | N/A | +1569.2% |
| All | -$138.71M | +423.8% |
EBITDA History
FAQ
What is the current annual EBITDA of ALKS?
As of today, ALKS annual EBITDA is $449.17M
What is 1-year change in ALKS annual EBITDA?
ALKS annual EBITDA is down -8.15% year-over-year
What is 3-year change in ALKS annual EBITDA?
ALKS annual EBITDA is up +809.89% over the past 3 years
How far is ALKS annual EBITDA from its all-time high?
ALKS annual EBITDA is currently -8.15% below its historical high of $489.05M set on December 31, 2023
How does ALKS annual EBITDA rank versus sector peers?
ALKS annual EBITDA is higher than 91.02% of companies in Healthcare sector
When is ALKS next annual earnings release?
The next annual earnings release for ALKS is on
Quarterly EBITDA
$97.16M$3.64M-3.61%
Summary
- Current Value
- As of today, ALKS quarterly EBITDA is $97.16M, down -3.61% on
- Historical Performance
- ALKS quarterly EBITDA is down -13.04% year-over-year, and up +336.72% over the past 3 years
- All-Time High Comparison
- ALKS quarterly EBITDA is currently -62.37% below its historical high of $258.20M set on
- 3-Year Low Comparison
- ALKS quarterly EBITDA is +1154.99% above its 3-year low of $7.74M reached on
- Sector Comparison
- ALKS quarterly EBITDA is higher than 88.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $97.16M | -3.6% | -13.0% | +336.7% | +880.2% | |
| Annual EBITDA | $449.17M | – | -8.2% | +809.9% | +9001.7% | |
| TTM EBITDA | $388.71M | -3.6% | +10.3% | +1072.4% | +329.9% | |
| Price | $29.36 | -5.1% | +2.9% | +8.3% | +42.6% | |
| PE Ratio | 14.53 | -5.1% | +11.0% | – | – | |
| Quarterly Revenue | $394.19M | +0.9% | +4.2% | +56.2% | +48.7% | |
| Quarterly EPS | $0.49 | -5.1% | -11.2% | +226.1% | +10000.0% | |
| Quarterly EBIT | $89.08M | -4.2% | -15.0% | +246.9% | +935.1% | |
| Quarterly Net Income | $82.76M | -5.0% | -10.8% | +229.4% | +10000.0% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $169.54M | N/A | -42.7% |
| 3Y | $258.20M | -62.4% | |
| 5Y | $258.20M | -62.4% | |
| All | $258.20M | -62.4% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $21.21M | +358.0% | |
| 3Y | $7.74M | +1155.0% | |
| 5Y | -$41.04M | +336.7% | |
| All | -$56.71M | +271.3% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of ALKS?
As of today, ALKS quarterly EBITDA is $97.16M
What is ALKS quarterly EBITDA most recent change?
ALKS quarterly EBITDA was down -3.61% on September 30, 2025
What is 1-year change in ALKS quarterly EBITDA?
ALKS quarterly EBITDA is down -13.04% year-over-year
How far is ALKS quarterly EBITDA from its all-time high?
ALKS quarterly EBITDA is currently -62.37% below its historical high of $258.20M set on June 30, 2023
How does ALKS quarterly EBITDA rank versus sector peers?
ALKS quarterly EBITDA is higher than 88.72% of companies in Healthcare sector
When is ALKS next earnings release?
The next earnings release for ALKS is on
TTM EBITDA
$388.71M$14.57M-3.61%
Summary
- Current Value
- As of today, ALKS TTM EBITDA is $388.71M, down -3.61% on
- Historical Performance
- ALKS TTM EBITDA is up +10.28% year-over-year, and up +1072.42% over the past 3 years
- All-Time High Comparison
- ALKS TTM EBITDA is currently -13.46% below its historical high of $449.17M set on
- 3-Year Low Comparison
- ALKS TTM EBITDA is +1457.78% above its 3-year low of -$28.63M reached on an earlier date
- Sector Comparison
- ALKS TTM EBITDA is higher than 89.08% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $388.71M | -3.6% | +10.3% | +1072.4% | +329.9% | |
| Annual EBITDA | $449.17M | – | -8.2% | +809.9% | +9001.7% | |
| Quarterly EBITDA | $97.16M | -3.6% | -13.0% | +336.7% | +880.2% | |
| Price | $29.36 | -5.1% | +2.9% | +8.3% | +42.6% | |
| PE Ratio | 14.53 | -5.1% | +11.0% | – | – | |
| TTM Revenue | $1.52B | +1.1% | +1.1% | +34.4% | +29.9% | |
| TTM EPS | $2.02 | -3.0% | +3.0% | +356.2% | +535.1% | |
| TTM EBIT | $358.54M | -4.2% | +14.7% | +400.5% | +4184.1% | |
| TTM Net Income | $338.06M | -2.9% | -12.6% | +361.8% | +559.5% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $449.17M | N/A | -13.5% |
| 3Y | $449.17M | -13.5% | |
| 5Y | $449.17M | -13.5% | |
| All | $449.17M | -13.5% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $388.71M | at low | |
| 3Y | -$28.63M | N/A | +1457.8% |
| 5Y | -$39.97M | +1072.4% | |
| All | -$188.07M | +306.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of ALKS?
As of today, ALKS TTM EBITDA is $388.71M
What is ALKS TTM EBITDA most recent change?
ALKS TTM EBITDA was down -3.61% on September 30, 2025
What is 1-year change in ALKS TTM EBITDA?
ALKS TTM EBITDA is up +10.28% year-over-year
How far is ALKS TTM EBITDA from its all-time high?
ALKS TTM EBITDA is currently -13.46% below its historical high of $449.17M set on December 31, 2024
How does ALKS TTM EBITDA rank versus sector peers?
ALKS TTM EBITDA is higher than 89.08% of companies in Healthcare sector
When is ALKS next earnings release?
The next earnings release for ALKS is on
EBITDA Formula
EBITDA = + + +
Data Sources & References
- ALKS Official Website www.alkermes.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1520262/000119312525252524/0001193125-25-252524-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1520262/000095017025019011/0000950170-25-019011-index.htm
- ALKS Profile on Yahoo Finance finance.yahoo.com/quote/ALKS
- ALKS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/alks